Merck, an American global pharmaceutical company, with headquarters in Kenilworth, New Jersey, was founded in 1891.
Merck has an employee count of about 70000 worldwide. Merck was featured as #241 in the 2015 Global 500 and as 71 in the 2015 Fortune 500 Companies list & With annual revenue of $39.498 billion, R & D expenditure of $6.704 billion and a basic EPS of $1.58 in 2015, Merck emerges as the fifth top pharmaceutical company in the world.
Merck has four major revenue contributors, namely
2 Animal Health,
3 Alliances and
4 Healthcare Services.
The Pharmaceuticals segment is further subdivided into: Primary care and Women’s Health (consisting of drugs for cardiovascular illnesses and diabetes, generic medicines and women’s healthcare products), Hospital and Specialty (consisting of formulations for hepatitis, HIV, immunological disorders and hospital acute care products) and Respiratory divisions.
Merck’s strive in bringing new healthcare products to the market through a dedicated R & D is partly showcased by the upcoming presentation of the overall survival data of Keytruda, a cancer treatment drug in the Phase III of clinical trials at the ASO Annual Conference, as announced by Merck in May 2016. Also, Merck has about 40 products in its pipeline under various phases of trial and expecting commercialization in the near future.